JPRN-jRCTs031190031招募中2 期
Efficacy of triple therapy with vonoprazan, amoxicillin, and sitafloxacin as a third-line Helicobacter pylori eradication regimen
Soichiro Sue0 个研究点目标入组 68 人开始时间: 2019年5月27日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 68
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •First line eradication(PPI+AMPC+CAM) and second line eradication(PPI+AMPC+MNZ) failure patients with H.pylori infection who want to take eradication treatment. Patients who give a written informed consent.
排除标准
- •Pregnancy or lactation. Past history of allergy for the drugs used in this therapy. Severe liver dysfunction, Severe renal dysfunction, Severe heart dysfunction. Patients who are disqualified for the study by physicians.
研究者
相似试验
招募中
2 期
VCM eradication therapy for penicillin allergyHelicobacter pylori infectionJPRN-jRCTs031200171Sue Soichiro30
已完成
4 期
Efficacy of vonoprazan-based dual therapy and vonoprazan-based triple therapy for Helicobacter pylori eradication: A prospective randomized studyvonoprazan, dual therapy, triple therapy, Helicobacter pylori eradicationHelicobacter pylori infectionTCTR20210623008Department of Medicine, Chulabhorn International College of Medicine (CICM) at Thammasat University100
招募中
不适用
Comparison of vonoprazan-based dual therapy with amoxicillin and the triple therapy with amoxicillin and clarithromycin for H. Pylori EradicatioH. pylori infectionJPRN-UMIN000022922Ministry of health, labor and welfare100
尚未招募
4 期
Vonoprazan-containing Triple Therapy Versus Empiric Bismuth Quadruple Therapy for First-line Helicobacter Pylori Treatment: a Randomized Clinical TrialHelicobacter Pylori InfectionNCT05726734Shanghai East Hospital100
Unknown
2 期
Efficacy of Vonoprazan based therapy (Vonoprazan, Amoxycillin, Levofloxacin) versus Omeprazole based standard therapy for Helicobacter Pylori: A Multicenter Randomized Controlled TrialEradication rateHelicobacter pylori infectionTCTR20221226002Phramongkutklao hospital158